| Incannex Healthcare Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | ||||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | ||||||||||||||||||||||||||||||||||||||||||
| Price to Sales | 1,770.87x | 1,890.14x | 73.34x | 2.19x | 6.38x | ||||||||||||||||||||||||||||||||||||||||||||
| Forward Price to Sales MRQ | - | - | - | - | 782.90x | 118.61x | 1.97x | - | |||||||||||||||||||||||||||||||||||||||||
| Price to Book | 11.37x | 12.14x | .47x | 1.74x | 38.98x | 5.32x | 4.08x | 4.00x | |||||||||||||||||||||||||||||||||||||||||
| Price to Earnings | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||
| Forward Price to Earnings MRQ | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||
| Debt to Asset Ratio | .35x | .54x | .91x | .59x | .34x | .18x | .16x | .12x | |||||||||||||||||||||||||||||||||||||||||
| Current Ratio | 2.86x | 2.12x | 1.80x | 1.65x | 2.88x | 5.70x | 6.70x | 9.02x | |||||||||||||||||||||||||||||||||||||||||